Rosuvastatin calcium-loaded Solid Lipid Nanoparticles (SLN) using design of experiment approach for oral delivery
This investigation utilizes quality-by-design approach to develop the Rosuvastatin Calcium (Rst)-loaded solid lipid nanoparticles (SLN). Effect of formulation variables such as amount of lipid (200-500 mg stearic acid) and surfactant concentration (0.5-2.0% PVA) were studied. Design of Experiment (DoE) was used to quantify the extent of impact of lipid amount and surfactant concentration on the physicochemical properties of the SLN and to identify optimized SLN formulation. It was observed that interplay of formulation variables had significant effect on particle size (198.25 to 622.36 nm), %EE (28.82 to 35.87%) and In vitro release (44.87 to 64.29%). Based on the results, point optimization was carried out to obtain the SLN with minimum particle size (202.5 ± 9.29 nm), maximum %EE (34.78 ± 0.37 %) and sustained In vitro release (57.3 ± 2.6 % at 36 hours) within the design space. In vitro drug release data fitted well in Korsmeyer-peppas model indicating the fickian diffusion mechanism. Ex vivo studies indicated sustained permeation of the Ropt compared to the control. Furthermore, stability studies indicated Ropt formulation exhibited no significant physical or chemical change under accelerated conditions.
Ridker PM, Danielson E, Fonseca FAH, Genest J, Gotto AM, Kastelein JJP, et al. Rosuvastatin to Prevent Vascular Events in Men and Women with Elevated C-Reactive Protein. N Engl J Med [Internet]. 2008 Nov 20;359(21):2195–207. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18997196
Tiwari R, Pathak K. Statins therapy: a review on conventional and novel formulation approaches. J Pharm Pharmacol [Internet]. 2011 Aug;63(8):983–98. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21718281
Balakumar K, Raghavan CV, selvan NT, prasad RH, Abdu S. Self-nanoemulsifying drug delivery system (SNEDDS) of Rosuvastatin calcium: Design, formulation, bioavailability and pharmacokinetic evaluation. Colloids Surfaces B Biointerfaces [Internet]. 2013 Dec 1;112:337–43. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24012665
Jain S, Patel N, Lin S. Solubility and dissolution enhancement strategies: current understanding and recent trends. Drug Dev Ind Pharm [Internet]. 2015 Jun 3;41(6):875–87. Available from: http://www.tandfonline.com/doi/full/10.3109/03639045.2014.971027
Kapure VJ, Pande V V., Deshmukh PK. Dissolution Enhancement of Rosuvastatin Calcium by Liquisolid Compact Technique. J Pharm [Internet]. 2013 Feb 27;2013:1–9. Available from: http://www.hindawi.com/journals/jphar/2013/315902/
Patel ZB, Patel KS, Shah AS, Surti NI. Preparation and optimization of microemulsion of rosuvastatin calcium. J Pharm Bioallied Sci [Internet]. 2012 Mar; 4 (Suppl 1):S118-9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23066186
Shah MK, Madan P, Lin S. Preparation, in vitro evaluation and statistical optimization of carvedilol-loaded solid lipid nanoparticles for lymphatic absorption via oral administration. Pharm Dev Technol [Internet]. 2013;1083–7450. Available from: http://informahealthcare.com/phd
Bunjes H. Lipid nanoparticles for the delivery of poorly water-soluble drugs. J Pharm Pharmacol [Internet]. 2010 Nov 1;62(11):1637–45. Available from: http://doi.wiley.com/10.1111/j.2042-7158.2010.01024.x
Hu L, Xing Q, Meng J, Shang C. Preparation and Enhanced Oral Bioavailability of Cryptotanshinone-Loaded Solid Lipid Nanoparticles. AAPS PharmSciTech [Internet]. 2010 Jun 30; 11(2):582–7. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20352534
Shah MK, Madan P, Lin S. Elucidation of intestinal absorption mechanism of carvedilol-loaded solid lipid nanoparticles using Caco-2 cell line as an in-vitro model. Pharm Dev Technol. 2014;0:1–9.
Jain S, Patel N, Shah MK, Khatri P, Vora N, Paudel KS, et al. Recent Advances in Lipid-Based Vesicles and Particulate Carriers for Topical and Transdermal Application. J Pharm Sci. 2016 Nov;0(0):109–31.
Dudhipala N, Veerabrahma K. Improved anti-hyperlipidemic activity of Rosuvastatin Calcium via lipid nanoparticles: Pharmacokinetic and pharmacodynamic evaluation. Eur J Pharm Biopharm [Internet]. 2017 Jan; 110:47–57. Available from: http://www.ncbi.nlm.nih.gov/pubmed/27810472
Abo Enin HA. Self-nanoemulsifying drug-delivery system for improved oral bioavailability of rosuvastatin using natural oil antihyperlipdemic. Drug Dev Ind Pharm [Internet]. 2015 Jul 3; 41(7):1047–56. Available from: http://www.ncbi.nlm.nih.gov/pubmed/25404208
Shah M. Solid Lipid Nanoparticles (SLN) for Oral Drug Delivery: An Overview. J Nanomed Nanosci [Internet]. 2017; Available from: http://gavinpublishers.com/wp-content/uploads/2017/06/JNAN-109.pdf
Hu L, Tang X, Cui F. Solid lipid nanoparticles (SLNs) to improve oral bioavailability of poorly soluble drugs. J Pharm Pharmacol. 2004 Dec;56(12):1527–35.
Mukherjee S, Ray S, Thakur RS. Solid lipid nanoparticles: a modern formulation approach in drug delivery system. Indian J Pharm Sci [Internet]. 2009 Jul [cited 2016 Oct 11]; 71(4):349–58. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20502539
Huang Y, Dai W-G. Fundamental aspects of solid dispersion technology for poorly soluble drugs. Acta Pharm Sin B [Internet]. 2014 Feb;4(1):18–25. Available from: http://linkinghub.elsevier.com/retrieve/pii/S2211383513000968
Mehnert W, Mäder K. Solid lipid nanoparticles: Production, characterization and applications. Adv Drug Deliv Rev. 2001; 47(2):165–96.
Jain S, Patel N, Madan P, Lin S. Quality by design approach for formulation, evaluation and statistical optimization of diclofenac-loaded ethosomes via transdermal route. Pharm Dev Technol [Internet]. 2015 May 19; 20(4):473–89. Available from: http://www.ncbi.nlm.nih.gov/pubmed/24490793
Patel N, Jain S, Madan P, Lin S. Application of design of experiments for formulation development and mechanistic evaluation of iontophoretic tacrine hydrochloride delivery. Drug Dev Ind Pharm [Internet]. 2016 Nov 10; 42(11):1894–902. Available from: https://www.tandfonline.com/doi/full/10.1080/03639045.2016.1181646
Bei Y-Y, Zhou X-F, You B-G, Yuan Z-Q, Chen W-L, Xia P, et al. Application of the central composite design to optimize the preparation of novel micelles of harmine. Int J Nanomedicine [Internet]. 2013; 8:1795–808. Available from: http://www.ncbi.nlm.nih.gov/pubmed/23674893
Vemulapalli V, Banga AK, Friden PM. Optimization of Iontophoretic Parameters for the Transdermal Delivery of Methotrexate. Drug Deliv [Internet]. 2008 Jan 16; 15(7):437–42. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18712621
Agarwal R, Malthar H, Madhumathi C, Chaitanya B. Development and pharmacodynamic evaluation of rosuvastatin-loaded nanostructured lipid carriers for oral. 2015; Available from: http://www.wjpps.com/download/article/1435655866.pdf
Xinsheng Peng J, Fang X, Zhou Y, Wang J, Guo F, Li F, et al. Development and optimization of solid lipid nanoparticle formulation for ophthalmic delivery of chloramphenicol using a Box-Behnken design. Int J Nanomedicine [Internet]. 2011 Apr;6:683. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21556343
Chen C-C, Tsai T-H, Huang Z-R, Fang J-Y. Effects of lipophilic emulsifiers on the oral administration of lovastatin from nanostructured lipid carriers: Physicochemical characterization and pharmacokinetics. Eur J Pharm Biopharm [Internet]. 2010 Mar;74(3):474–82. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20060469
Araújo J, Gonzalez-Mira E, Egea MA, Garcia ML, Souto EB. Optimization and physicochemical characterization of a triamcinolone acetonide-loaded NLC for ocular antiangiogenic applications. Int J Pharm [Internet]. 2010 Jun 30;393(1–2):168–76. Available from: http://www.ncbi.nlm.nih.gov/pubmed/20362042
Ghadiri M, Fatemi S, Vatanara A, Doroud D, Najafabadi AR, Darabi M, et al. Loading hydrophilic drug in solid lipid media as nanoparticles: Statistical modeling of entrapment efficiency and particle size. Int J Pharm [Internet]. 2012 Mar 15;424(1–2):128–37. Available from: http://www.ncbi.nlm.nih.gov/pubmed/22227603
Schubert M, Müller-Goymann C. Solvent injection as a new approach for manufacturing lipid nanoparticles–evaluation of the method and process parameters. Eur J Pharm [Internet]. 2003 [cited 2016 Jun 22]; Available from: http://www.sciencedirect.com/science/article/pii/S0939641102001303
Zhang J, Fan Y, Smith E. Experimental Design for the Optimization of Lipid Nanoparticles. J Pharm Sci [Internet]. 2009 May;98(5):1813–9. Available from: http://www.ncbi.nlm.nih.gov/pubmed/18781636
Varshosaz J, Ghaffari S, Khoshayand MR, Atyabi F, Dehkordi AJ, Kobarfard F. Optimization of freeze-drying condition of amikacin solid lipid nanoparticles using D-optimal experimental design. Pharm Dev Technol [Internet]. 2012 Apr 4;17(2):187–94. Available from: http://www.ncbi.nlm.nih.gov/pubmed/21047276
Ferreira SLC, Bruns RE, da Silva EGP, dos Santos WNL, Quintella CM, David JM, et al. Statistical designs and response surface techniques for the optimization of chromatographic systems. J Chromatogr A [Internet]. 2007 Jul;1158(1–2):2–14. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0021967307005298
Bezerra MA, Santelli RE, Oliveira EP, Villar LS, Escaleira LA. Response surface methodology (RSM) as a tool for optimization in analytical chemistry. Talanta [Internet]. 2008 Sep 15;76(5):965–77. Available from: http://linkinghub.elsevier.com/retrieve/pii/S0039914008004050
Shah R, Eldridge D, Palombo E. Optimisation and stability assessment of solid lipid nanoparticles using particle size and zeta potential. J Phys [Internet]. 2014; Available from: http://search.proquest.com/openview/a5f35101556340cb727510843c5b1486/1?pq-origsite=gscholar&cbl=2032013
Parhi R, Suresh P. Preparation and characterization of solid lipid nanoparticles-a review. Curr Drug Discov Technol [Internet]. 2012; Available from: http://www.ingentaconnect.com/content/ben/cddt/2012/00000009/00000001/art00002.
Copyright (c) 2017 Anjali Beniwal
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
International Journal of Chemical and Life Sciences
ISSN NO: 2234-8638
Sub: Submission of an original paper with copyright agreement and
authorship responsibility (submit by e-mail only)
I certify that I have participated sufficiently in the
conception and design of this work and the analysis of the data
(wherever applicable), as well as the writing of the manuscript, to
take public responsibility for it. I believe the manuscript represents
valid work. I have reviewed the final version of the manuscript and
approve it for publication. Neither the manuscript nor one with
substantially similar content under my authorship been published or
is being considered for publication elsewhere, except as described in
an attachment. Furthermore I attest that I shall produce the data
upon which the manuscript is based for examination by the editors
or their assignees, if requested. Kindly find it suitable to publish in
your esteemed journal.
Author name, address and Signature